CYCLO THERAPEUTICS INC (CYTH) Stock Analyst Ratings
USA - NASDAQ:CYTH - US23254X2018 - Common Stock
0.7206 USD
+0.01 (+1.39%)
0.7199 USD
0 (-0.1%)
ChartMill assigns a Buy % Consensus number of 78% to CYTH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 0.97. This target is 34.47% above the current price.
CYTH was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CYTH.
In the previous month the buy percentage consensus was at a similar level.
CYTH was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-27 | Maxim Group | Downgrade | Buy -> Hold |
| 2024-08-26 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-08-23 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-08-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-01 | HC Wainwright & Co. | Initiate | Buy |
| 2024-04-22 | Ascendiant Capital | Initiate | Buy |
| 2023-09-27 | Maxim Group | Upgrade | Hold -> Buy |
| 2023-03-21 | Maxim Group | Downgrade | Buy -> Hold |
CYCLO THERAPEUTICS INC / CYTH FAQ
What is the average price target for CYCLO THERAPEUTICS INC (CYTH) stock?
9 analysts have analysed CYTH and the average price target is 0.97 USD. This implies a price increase of 34.47% is expected in the next year compared to the current price of 0.7206.
What is the consensus rating for CYCLO THERAPEUTICS INC (CYTH) stock?
The consensus rating for CYCLO THERAPEUTICS INC (CYTH) is 77.7778 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover CYCLO THERAPEUTICS INC (CYTH) stock?
The number of analysts covering CYCLO THERAPEUTICS INC (CYTH) is 9.